BMYB34:BVMF
Bristol Myers Squibb
331,90 R$
arrow_upward
+0,65%(+2,15) 1K
30-sen, 11:31:25 (GMT-3) · BRL
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBMYB34 tikeri uchun statistika yaratilmoqda...
Bozor kapitali
120,13 mlrd
Oʻrtacha hajm
10,00
Hajmi
0,00
52 haftalik eng yuqori
347,15 R$
52 haftalik eng past
221,72 R$
Muomaladagi aksiyalar
2,04 mlrd
Xodimlar soni
32 ming
Bozor kapitali
120,13 mlrd
Oʻrtacha hajm
10,00
Hajmi
0,00
52 haftalik eng yuqori
347,15 R$
52 haftalik eng past
221,72 R$
Muomaladagi aksiyalar
2,04 mlrd
Xodimlar soni
32 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
1 soat oldin
Leerink cuts target for Bristol Myers Squibb stock to USD 59.00
The Globe and Mail
·
3 soat oldin
Zacks.com featured highlights Dollar General, Bristol-Myers Squibb and Equinor ASA
GuruFocus
·
6 soat oldin
Bristol-Myers Squibb Co (BMY) Shares Fall 3.8% -- GF Value Says Still Overvalued
Profil
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Bristol Myers Squibb haqida
CEOChris Boerner
Xodimlar soni32,5 ming
Asos solingan1887
Bosh ofislarNyu-York shahri, Nyu-York, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytbms.com